Nature Precedings to stop accepting submissions next week after finding model “unsustainable”

After five years of operation, the Nature Publishing Group is will no longer accept submissions to its preprint server Nature Precedings, having found the experiment “unsustainable as it was originally conceived.”

Here’s the announcement sent to all Nature Precedings registrants this morning: Continue reading Nature Precedings to stop accepting submissions next week after finding model “unsustainable”

Three more retractions for resveratrol researcher Dipak Das, in free radical journals

Das, via UConn

The retraction count for Dipak Das, the resveratrol researcher whom the University of Connecticut found to have committed 145 counts of fabrication and falsification of data, has risen to eight with withdrawals by Free Radical Biology & Medicine and Free Radical Research.

The two Free Radical Biology & Medicine retractions, for “Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol” (cited 38 times, according to Thomson Scientific’s Web of Knowledge) and “Redox regulation of resveratrol-mediated switching of death signal into survival signal” (cited 32 times), are carefully detailed and read the same way: Continue reading Three more retractions for resveratrol researcher Dipak Das, in free radical journals

Japanese universities find pair of researchers guilty of misconduct in 19 papers

Kenji Okajima

We have an update in the case of two Japanese scientists who first came to our attention when they retracted a 13-year-old paper in the Journal of Neuroscience last year. Shortly after that, we learned, thanks to a report in Sankei Shimbun and a helpful Retraction Watch reader, that some 17 papers were being investigated.

It now appears that 19 papers by the two researchers, Kenji Okajima and Naoki Harada, ended up under scrutiny.

Nagoya City University said last week that their investigation had concluded that Okajima and Harada committed misconduct. The university dismissed Harada, whom they found guilty of misconduct in at least eight of the papers. The investigation couldn’t find any evidence that Okajima was directly involved, but suspended him for six months because he supervised the work. Continue reading Japanese universities find pair of researchers guilty of misconduct in 19 papers

Rabbits needn’t worry about cell phones’ effects on their sperm count, say three retractions

If you’re a rabbit and you haven’t figured out where to carry your cell phone, your front pocket is just fine.

That’s what you could reasonably infer from the retraction of a paper in the International Journal of Andrology purporting to show that mobile phones affected rabbits’ sperm counts. The notice, signed by the journal’s editor, Ewa Rajpert-De Meyts (we added links): Continue reading Rabbits needn’t worry about cell phones’ effects on their sperm count, say three retractions

PNAS author explains why she didn’t sign retraction notice for potential anti-cancer drug study

On Tuesday, we covered a retraction in the Proceedings of the National Academy of Sciences (PNAS) involving zalutumumab, a compound once being developed for treatments of head and neck cancer. As we noted at the time, the authors decided to retract the paper because they no longer trusted the method they used. One of the authors didn’t sign the notice, and we’ve now heard from her about why.

First, a comment from lead author Paul W.H.I Parren, who tells Retraction Watch: Continue reading PNAS author explains why she didn’t sign retraction notice for potential anti-cancer drug study

Another non-unanimous PNAS retraction, for potential anti-cancer drug, after company’s method proves unreliable

There’s another non-unanimous retraction in the Proceedings of the National Academy of Sciences (PNAS) this week, and this one involves an anti-tumor antibody that may not be what the authors originally thought it was.

According to the notice for “The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility:” Continue reading Another non-unanimous PNAS retraction, for potential anti-cancer drug, after company’s method proves unreliable

Authors retract paper claiming antidepressants prevent suicide

The authors of a study allegedly showing that antidepressants prevent suicide have retracted it over unspecified errors. Here’s the notice:

At the request of the authors and in agreement with the Editor-in-Chief and Wiley-Blackwell, the following article “Antidepressant medication prevents suicide in depression”. Acta Psychiatr Scand 2010;122:454–460 has been retracted. The retraction has been requested and agreed due to unintentional errors in the analysis of the data presented.

The original paper linked “data on the toxicological detection of antidepressants in 18 922 suicides in Sweden 1992–2003” to “registers of psychiatric hospitalization as well as registers with sociodemographic data.” It found: Continue reading Authors retract paper claiming antidepressants prevent suicide

Watch and learn, science journals: “This American Life” retracts Mike Daisey segment on Apple in China

“This American Life,” the popular radio show hosted by Ira Glass, is retracting an episode in which monologist Mike Daisey claimed to have described conditions in a Chinese factory that makes electronic devices, including Apple products. According to a note about this week’s episode:

Regrettably, we have discovered that one of our most popular episodes was partially fabricated. This week, we devote the entire hour to detailing the errors in “Mr. Daisey Goes to the Apple Factory,” Mike Daisey’s story about visiting Foxconn, an Apple supplier factory in China. Rob Schmitz, a reporter for Marketplace, raises doubts on much of Daisey’s story.

Ira also talks with Mike Daisey about why he misled This American Life during the fact-checking process. And we end the show separating fact from fiction, when it comes to Apple’s manufacturing practices in China.

A This American Life press release spells out why the show retracted the segment, and it isn’t pretty. The doubts started with Rob Schmitz, who interviewed Daisey’s Chinese interpreter, Li Guifen. (She  goes by Cathy Lee professionally with Westerners, according to the release.) A lot of what Daisey had attributed to Lee was false, she said. And that came on top of the fact that Daisey had told This American Life fact-checkers that Lee’s name was Anna, and that he didn’t have a way to reach her anymore. Glass is quoted in the press release: Continue reading Watch and learn, science journals: “This American Life” retracts Mike Daisey segment on Apple in China

A non-unanimous retraction in PNAS after authors are “unable to reproduce the data”

A group of authors has retracted a 2009 paper in the Proceedings of the National Academy of Sciences (PNAS) after subsequent experiments suggested their original results weren’t holding up.

According to the notice for the paper, which has been cited 8 times, according to Thomson Scientific’s Web of Knowledge: Continue reading A non-unanimous retraction in PNAS after authors are “unable to reproduce the data”

Hold the broccoli, garlic, and wine: Three Dipak Das retractions appear in Journal of Agricultural and Food Chemistry

The Journal of Agricultural and Food Chemistry has retracted three papers by Dipak Das, the resveratrol researcher found to have committed more than 100 counts of fraud by the University of Connecticut.

Journal editor James Seiber writes: Continue reading Hold the broccoli, garlic, and wine: Three Dipak Das retractions appear in Journal of Agricultural and Food Chemistry